Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12): long-term results
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference23 articles.
1. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer;Armstrong;Int. J. Radiat. Oncol. Biol. Phys.,1993
2. GETCB, F. ASTRO plenary: Effect of chemotherapy on locally advanced nonsmall cell lung carcinoma: A randomized study of 353 patients;Arriagada;Int. J. Radiat. Oncol. Biol. Phys.,1991
3. Cancer statistics;Boring;CA Cancer J. Clin.,1993
4. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.
5. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in Stage III nonsmall cell lung cancer;Dillman;N. Engl. J. Med.,1990
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction);La radiologia medica;2019-07-17
2. Imaging of Radiation Treatment of Lung Cancer;Seminars in Ultrasound, CT and MRI;2018-06
3. Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance);International Journal of Radiation Oncology*Biology*Physics;2018-05
4. Computed tomography-guided intraluminal brachytherapy in recurrent bronchogenic carcinoma: A clinical trial in a small group;Precision Radiation Oncology;2017-06
5. Therapeutic management options for stage III non-small cell lung cancer;World Journal of Clinical Oncology;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3